ScreenerHero

VAXX Vaxxinity Inc. Class A Common Stock

Partial data
NAS · US · Healthcare · Biotechnology · vaxxinity.com
0.0001USD0.00%Mkt Cap: 12678 $P/E: —

Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology, cardiovascular diseases, and coronaviruses in the United States. Its product pipeline comprises…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap12.68K USD
Enterprise Value-15.46M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-56.93M USD
Revenue/Share—
Last Price0.0001 USD
Fiscal Year EndDec 2023
MR QuarterDec 2023
Employees57
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.00
PEG—
EV/EBITDA0.28
EV/Revenue—
P/S—
P/B0.00
EPS (TTM)-0.05
EPS (Forward)-0.38
52W Range
0.00010% of range0.2000
52W High0.2000 USD
52W Low0.0001 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-424.60%
ROA-128.49%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-57.24M USD
CapEx (TTM)803.00K USD
FCF Margin—
FCF Yield-294818.77%
Net Debt-15.47M USD
Net Debt/EBITDA0.28
Balance Sheet
Debt/Equity1.13
Current Ratio1.89
Quick Ratio1.76
Book Value/Sh0.11 USD
Cash/Share0.24 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.112.91M
Float112.87M
Insiders0.00%
Institutions0.02%
Short Interest
Short Ratio14.0d
Short % Float108.73%
Short % Out.3.33%
Shares Short4.22M
Short (prev mo.)3.85M
Technical
SMA 500.0031 (-96.8%)
SMA 2000.0035 (-97.1%)
Beta-76.39
S&P 52W Chg16.67%
Avg Vol (30d)4.37K
Avg Vol (10d)9.98K
Technical Indicators
RSI (14)45.9
MACD0.0000
MACD Signal0.0009
MACD Hist.-0.0009
BB Upper0.0217 USD
BB Middle0.0049 USD
BB Lower-0.0120 USD
BB Width692.68%
ATR (14)0.0071 USD
Vol Ratio (20d)0.00x